While slow breathing is not necessarily an instructed component in mindfulness practice, it can happen as a consequence of mindfulness meditation (Wahbeh et al.,
2016), and had been integrated with mindfulness practice to form combined intervention technique (Kim et al.,
2013). It has been found that slow-paced breathing shows high efficacy in reducing daily stress (Balters et al.,
2020), and in promoting mental wellness under chronic stress (Borges et al.,
2021). As stress is known to activate the hypothalamus–pituitary–adrenal (HPA) axis that in turn leads to widespread physiological consequences particularly in the cardiovascular systems (Golbidi et al.,
2015), the effectiveness of slow-paced breathing in enhancing cardiovascular health is particularly noteworthy. It was theorized that through resonating with heart rate and blood pressure oscillations, slow-paced breathing positively influences the body’s baroreflex system that allows more effective self-regulation of cardiovascular functions (Lehrer & Gevirtz,
2014). Accumulating evidence supports the efficacy of slow-paced breathing in treating hypertension/prehypertension (Cernes & Zimlichman,
2017), and in improving cardiovascular control in patients with chronic heart failure (Mangin et al.,
2001). Further, intricate associations exist between cardiovascular disease and mood disorders such as depression and anxiety, both of which could be triggered by chronic stress (Chaddha,
2015). In this context, a systematic synthesis of existing literature on the effects of slow-paced breathing on cardiovascular and emotional processes is important for elucidating the psychophysiological mechanisms underlying its therapeutic efficacy.
Heart rate (HR) and blood pressure (BP) are core indices of cardiovascular function. HR refers to the speed of the heartbeat. While normal resting HR ranges between 60–100 beats/min, overly high HR (tachycardia) is associated with major cardiovascular diseases such as myocardial infarction and coronary artery disease (Palatini & Julius,
2004). HR is modulated by breathing pattern through the relative balance of the autonomic nervous system (Eckberg et al.,
1985). Specifically, during inhalation the vagal control is decreased, which allows HR to increase as part of the parasympathetic process. In contrast, during exhalation the vagal outflow is restored, and the HR decreases as a consequence. The individual’s ability to regulate autonomic activity is reflected by heart rate variability (HRV), which can be quantified in time or frequency domain. For instance, the root-mean-square-of-successive-differences-between-normal-heartbeats, or RMSSD, reflects the beat-to-beat interval variance and is a primary time-domain HRV measure for vagally mediated changes (Shaffer & Ginsberg,
2017). On the other hand, HRV could be decomposed into a high-frequency (HF, 0.15–0.40 Hz) and a low-frequency (LF, 0.04–0.15 Hz) component. It was proposed that both the HF and LF components may mainly reflect parasympathetic activities (Reyes del Paso et al.,
2013). Moreover, HRV has a very low frequency component, which is a representation of sympathetic activity, as well as an ultra-low frequency component. Generally, overly low HRV may indicate hyperactive sympathetic system or insufficient parasympathetic modulation, and is associated with increased risk for coronary heart disease (Dekker et al.,
2000), as well as for dysphoria states and mood disorders (Carney & Freedland,
2009; Kawachi et al.,
1994).
BP refers to arterial pressure related to cardiac output, arterial elasticity and peripheral resistance (Shahoud et al.,
2023). Systolic blood pressure (SBP) measures the maximal pressure within the arteries as the heart muscle contracts and propels blood to the body. Diastolic blood pressure (DBP) measures the lowest pressure within the arteries as the heart muscle relaxes between heart beats (Shahoud et al.,
2023). Under natural conditions, BP is under the influence of respiratory processes. During inhalation the thoracic pressure decreases, which indirectly lead to pulmonary resistance increase and the pulmonary venous return decrease, resulting in reduced blood in-flow to the heart and decrease in BP. Conversely, during exhalation, both ventricular blood volume and BP increase. It has been shown that breathing characteristics, such as frequency and depth, could influence BP (Anderson et al.,
2010; Grossman et al.,
2001). Furthermore, BP is routinely regulated by the arterial baroreflex, which is a negative feedback mechanism that monitors arterial BP through neural and autonomic pathways (Eckberg et al.,
1980). Past studies showed that slow-paced breathing improved arterial baroreflex sensitivity in both healthy individuals and patients with chronic heart failure (Bernardi et al.,
2002), and in hypertensive patients (Joseph et al.,
2005). Given that baroreflex sensitivity was found to be negatively related to BP (Hesse et al.,
2007), it could mediate the effect of slow-paced breathing in reducing BP. Both SBP and DBP elevations are closely associated with cardiovascular diseases and higher mortality (Kannel,
2000; Taylor et al.,
2011); hence their reductions following slow-paced breathing reflect a major therapeutic outcome.
Several reviews and meta-analyses exist which summarized previous research on the psychophysiological effects of slow-paced breathing (Chaddha et al.,
2019; Russo et al.,
2017; Sevoz-Couche & Laborde,
2022; Zaccaro et al.,
2018). The existing reviews suggested that slow-paced breathing improves cardiovascular functions such as increasing HRV (Zaccaro et al.,
2018), BP oscillations (Russo et al.,
2017), and decreasing SBP and DBP (Chaddha et al.,
2019). Slow-paced breathing additionally promoted positive emotional states and reduced negative emotional states such as anxiety and depression (Zaccaro et al.,
2018). These psychophysiological benefits were further linked with general improvements in stress regulation (Sevoz-Couche & Laborde,
2022). On the other hand, meta-analysis is a useful method that pools effects across studies, taking into account heterogeneities in study findings. To our awareness, only one meta-analysis (Chaddha et al.,
2019) quantified the effect of slow-paced breathing on BP and HR, which included hypertensive and pre-hypertensive patients only. Thus, this study’s results may not generalize to wider nonclinical populations. Also, not many existing reviews discussed whether multi-session slow-paced breathing training could produce long-term beneficial effects, which is critical for considering it as an efficacious intervention. Furthermore, the
association between the slow-paced breathing effect on physiological and emotion functions is still unclear, which is a noteworthy gap since it is widely acknowledged that our physiological and emotion systems interact closely with each other in bidirectional manners (Pace-Schott et al.,
2019).
Discussion
We conducted a meta-analysis of existing literature on the effects of slow-paced breathing on cardiovascular indices, including HR, HRV and BP, as well as on negative emotions. The results were that slow-paced breathing training showed a moderate effect in reducing SBP, a moderate-to-large effect in increasing time-domain HRV, and a small effect in reducing HR. However, slow-paced breathing did not significantly change frequency-domain HRV, or DBP. We also obtained modest evidence suggesting that slow-paced breathing may reduce negative emotions such as perceived stress. While preliminary evidence supports long-term (3 months) effect of slow-paced breathing in reducing both SBP and DBP among prehypertensive individuals, the results remained to be replicated among normotensive populations. Also, it was unclear whether slow-paced breathing alone could lead to robust and persistent reductions in BP, or complementary relaxation procedures are needed to produce the desirable outcomes. Furthermore, preliminary evidence indicated a moderate association between the physiological effects of slow-paced breathing and its effect in reducing negative emotions.
HR is controlled by activity of cardioinhibitory parasympathetic neurons located in the brain stem, and is modulated during the processes of inhalation and exhalation through the activity shifting between sympathetic and parasympathetic systems (Neff et al.,
2003). It is considered that slow-paced breathing at a rhythm close to the resonating frequency of the HR promotes self-regulation of cardiovascular functions (Lehrer & Gevirtz,
2014), such as decreased HR. Since abnormally high HR is frequently associated with major cardiovascular diseases (Palatini & Julius,
2004), reduction in HR may be linked to improvements in cardiovascular health. While our observed effect size on HR was small in magnitude, the heterogeneity in findings across studies was low, suggesting that this effect was consistent. Notably, in the only existing meta-analysis on the cardiovascular effects of slow-paced breathing, it was reported that device-guided slow-paced breathing had no significant effect on HR, and between-study heterogeneity was high (Chaddha et al.,
2019). Given that the study selectively included hypertensive and prehypertensive individuals, it could be that the slow breathing effect on HR is more variable among those with existing cardiovascular symptoms. Some of those patients were also on antihypertensive drugs, which may further contribute to the heterogeneous findings. Our meta-analysis is the first to quantify the slow breathing effect on HR among non-hypertensive individuals, and the findings revealed a small but reliable effect.
We found that slow-paced breathing resulted in a post-intervention increase of time-domain HRV, namely RMSSD and SDNN, with a moderate effect size. The RMSSD reflects short-term changes in instantaneous HR (or inter-beat interval), and reflects vagus-mediated regulation of the heart function (Stein et al.,
1994). Similarly, the SDNN is often considered to be reflective of vagal nerve activity level (Cherifi et al.,
2022). The vagus nerve exerts protective influence over heart function by release of acetylcholine at postganglionic muscarinic receptors and the sinoatrial node, and by inhibition of presynaptic norepinephrine release (Verrier & Antzelevitch,
2004). Substantial evidence indicates an association between low RMSSD and heart failure (Drawz et al.,
2013), carotid artery disease (Kadoya et al.,
2015), high plasma cholesterol level (Christensen et al.,
1999), as well as with Major Depression Disorder (Ohira et al.,
2008). Similarly, low SDNN had been linked with first occurrence of cardiovascular episode (Hillebrand et al.,
2013) and coronary artery disease (Evrengul et al.,
2006). The current meta-analysis results indicated a medium effect of slow-paced breathing in increasing RMSSD, with low between-study heterogeneity suggesting stability of the effect, while slow-paced breathing exerted a moderately high effect in increasing SDNN despite high between-study heterogeneity.
On the other hand, the meta-analysis revealed no significant effect of slow-paced breathing on frequency-domain HRV measures. It is considered that both the HF and LF components may mainly reflect parasympathetic activities (Reyes del Paso et al.,
2013). Some argued that the HF-HRV is highly correlated with RMSSD (Laborde et al.,
2017). However, unlike RMSSD, HF-HRV showed no significant increase following slow-paced breathing, although a tentative trend was revealed (
p = 0.15). The lack of statistically significant effect on HF-HRV measured post intervention could be due to the high between-study heterogeneity in this measure. Indeed, one previous simulation study found that due to inherent difficulty in frequency-based analysis, statistical errors in frequency-domain HRV analysis were much larger than those in time-domain HRV analysis, resulting in up to tenfold variability associated with the former measurement (Kuss et al.,
2008). This may explain why the observed effect on post-intervention HF-HRV (and LF-HRV) was not significant. The ratio of LF and HF HRV used to be considered as reflecting the autonomic balance of sympathetic and parasympathetic activities (e.g., Ghiya & Lee,
2012). However, later research indicates that the meaning of the LF/HF ratio is more ambiguous, as the sympathetic contribution of LF HRV was called into question (Shaffer et al.,
2014). The ambiguous physiological implication of the LF/HF ratio may be one reason that we found no significant effect of slow-paced breathing on this index.
High SBP is a major risk factor for cardiovascular disease and mortality. According to one study, SBP in the range of 120-124 mm Hg was associated with 64% reduced chance of developing cardiovascular disease, and 53% reduced chance of death, relative to SBP of 160 mm Hg or above (Bundy et al.,
2017). Moreover, even among healthy individuals with normal range of SBP (90-129 mm Hg), every 10 mm Hg increase of SBP was associated with 53% higher likelihood to develop atherosclerotic cardiovascular disease (Whelton et al.,
2020). In this context, our finding that slow-paced breathing significantly reduced post-intervention SBP at moderate-to-high effect size supported its beneficial effect on cardiovascular health. Furthermore, two longitudinal studies using prehypertensive samples showed that slow-paced breathing with or without muscle relaxation component significantly reduced SBP up to 3 months later (Lin et al.,
2012; Wang et al.,
2010), which provided preliminary support for using multisession slow-paced breathing to achieve long-term SBP decrease. On the other hand, the current meta-analysis revealed no significant change in DBP following slow-paced breathing. Substantial between-study heterogeneity was also observed, suggesting the effect on DBP may show considerable individual difference. One previous meta-analysis revealed significant reduction of DBP following slow-paced breathing among hypertensive and prehypertensive individuals (Chaddha et al.,
2019). In contrast, our results suggested that among nonclinical populations, slow-paced breathing may not have consistent effect on DBP. Existing evidence suggests that high SBP may convey greater risk for major cardiovascular diseases and death than high DBP (Glynn et al.,
2002; Williams et al.,
2008), and some considered SBP as the primary target for antihypertensive therapy (Strandberg & Pitkala,
2003). It remains to be determined whether slow-paced breathing may significantly decrease DBP among special populations (e.g., those with pre/hypertension).
It is well accepted that the physiological and emotion systems are closely related. According to the classic James-Lange theory, emotions emerge from the perception of physiological changes (Fehr & Stern,
1970; Pace-Schott et al.,
2019). Conversely, brain regions involved in emotion functions, such as the amygdala, innervate the brain stem and the hypothalamus, and in turn influence the autonomic nervous system and HPA system under stress (Flandreau et al.,
2012; Price & Drevets,
2010). Therefore, slow-paced breathing was expected to also influence emotional states. In this meta-analysis, we obtained limited evidence supporting the efficacy of slow-paced breathing in reducing negative emotions, particularly perceived stress. It is well-known that stress activates the body’s sympathetic nervous system, which constitutes the physiological component of the overarching stress responses (Hering et al.,
2015). Given slow-paced breathing is considered to shift the autonomic balance towards greater parasympathetic dominance over sympathetic activity (Russo et al.,
2017), it is possible that slow-paced is particularly effective in reducing perceived stress via enhancing parasympathetic-sympathetic dominance. Since high stress levels, particularly in the long term, is known to lead to major affective disorders such as major depression and anxiety (e.g., Hammen et al.,
2009; Hussenoeder et al.,
2022), it is also likely that slow-paced breathing reduces depressive and anxiety symptoms through decreasing perceived stress and its associated sympathetic nervous activity. On the other hand, the between-study heterogeneity level was high, which could be partly due to sex differences in the slow-paced breathing effect. Past evidence indicated that females tended to show more prolonged reactivity to negative emotions than males, which may explain their generally high state negative arousal (Gard & Kring,
2007). This may contribute to the observed sex difference in the effect of slow breathing effect on negative arousal (Szulczewski & Rynkiewicz,
2018). Future research may separately investigate the slow-paced breathing effect in reducing negative emotions in males and females.
Importantly, we assessed the association between physiological and negative emotion changes following slow-paced breathing training across studies, which to our knowledge had not been attempted previously. While the available number of studies was limited, we showed that the effect of slow-paced breathing in reducing negative emotions, particularly subjective stress, was moderately associated with its effect in reducing HR and boosting RMSSD measures. This result was consistent with a great body of past literature on the intimate link between the human physiological and emotion systems (Pace-Schott et al.,
2019), and highlights the possibility that slow-paced breathing might reduce negative emotions via its physiological benefits, and
vice versa. Clearly, more future studies need to further investigate the association between the physiological and emotion effects of slow-paced breathing, towards elucidating the comprehensive psychophysiological mechanisms of its multifaceted effects.
The current findings on the effects of slow-paced breathing can also be viewed in relation to the broader field of mindfulness practice effects. While not being an instructed component of mindfulness, slow-paced breathing can take place during mindfulness practice (Wahbeh et al.,
2016), be integrated with mindfulness components to form combined intervention (Kim et al.,
2013), and is more often observed in long-term meditation practitioners (Wielgosz et al.,
2016). Existing evidence indicates that mindfulness-based interventions resulted in reductions in HR, SBP and negative emotion symptoms (Christodoulou et al.,
2020; Pascoe et al.,
2017; Scott-Sheldon et al.,
2020). On the other hand, the effect of mindfulness on HRV measures including HF-HRV, LF-HRV, LF/HF ratio, RMSSD and SDNN were inconclusive (Brown et al.,
2021; Rådmark et al.,
2019). Thus, while previous findings on the physiological and emotional effects of mindfulness largely overlapped with our current results regarding the beneficial effects of slow-paced breathing, it appeared that slow-paced breathing may show greater effects on vagally-mediated HRV measures that reflect parasympathetic modulations (e.g., RMSSD), compared to mindfulness practice (Brown et al.,
2021). Notwithstanding, further well-controlled RCT studies on both mindfulness meditation and slow-paced breathing are needed to draw firmer conclusions.
Limitations and Future Research
Several major questions remain unanswered based on the existing literature. First, the long-term effect of slow-paced breathing on cardiovascular functions remained largely unclear. More longitudinal studies are needed to establish whether multisession slow-paced breathing can induce long-lasting benefits in major physiological measures. Second, future studies should standardize the intervention design, such as whether the comparison/control group is instructed to perform natural breathing, other distraction tasks, or simply “do nothing” (Sevoz-Couche & Laborde,
2022). Also, the timing of outcome measurement could affect the results, given the current findings indicate that outcomes measured during intervention could differ from those measured post-intervention. Fourth, the majority of existing studies measured slow-paced breathing outcomes during “resting” states, while only a few studies delivered stress-induction procedures and measured changes in participants’ physiological and emotional stress reactivity. It is still unclear whether slow-paced breathing has different effects on “resting” versus “stress-reactive” processes. Lastly, considerable individual differences in responding to slow-paced breathing intervention could mask a sample-average effect. The current review suggests that individual characteristics such as sex may modulate the effect of slow-paced breathing in reducing negative emotional states. These individual differences may also contribute to the between-study heterogeneity in findings. Future studies should further explore other physical and psychological traits that may modulate the slow-paced breathing effect.
In conclusion, the current meta-analysis showed that slow-paced breathing had significant immediate beneficial effects on SBP, HR and time-domain HRV (RMSSD and SDNN), but not on DBP or frequency-domain HRV. Slow-paced breathing also had a modest effect in reducing negative emotions, particularly perceived stress. The long-term effects on cardiovascular functions remained largely unclear, particularly for normotensive populations. Preliminary evidence indicated a moderate association of the slow-paced breathing effect in causing physiological changes and in reducing negative emotions.